Rule2025-17560
Extension of Expiration Dates for 13 Body System Listings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 11, 2025
Effective
September 11, 2025
Issuing agencies
Social Security Administration
Abstract
We are extending the expiration dates of the following body systems in the Listing of Impairments (listings) in our regulations: Low Birth Weight and Failure to Thrive, Musculoskeletal Disorders, Special Senses and Speech, Respiratory Disorders, Cardiovascular System, Genitourinary Disorders, Hematological Disorders, Endocrine Disorders, Congenital Disorders That Affect Multiple Body Systems, Neurological Disorders, Mental Disorders, Cancer (Malignant Neoplastic Diseases), and Immune System Disorders. We are making no other revisions to these body systems in this final rule. This extension ensures that we will continue to have the criteria we need to evaluate impairments in the affected body systems at step three of the sequential evaluation processes for initial claims and continuing disability reviews.
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 174 (Thursday, September 11, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 174 (Thursday, September 11, 2025)]
[Rules and Regulations]
[Pages 43911-43912]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-17560]
[[Page 43911]]
-----------------------------------------------------------------------
SOCIAL SECURITY ADMINISTRATION
20 CFR Part 404
[Docket No. SSA-2025-0033]
RIN 0960-AI95
Extension of Expiration Dates for 13 Body System Listings
AGENCY: Social Security Administration.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: We are extending the expiration dates of the following body
systems in the Listing of Impairments (listings) in our regulations:
Low Birth Weight and Failure to Thrive, Musculoskeletal Disorders,
Special Senses and Speech, Respiratory Disorders, Cardiovascular
System, Genitourinary Disorders, Hematological Disorders, Endocrine
Disorders, Congenital Disorders That Affect Multiple Body Systems,
Neurological Disorders, Mental Disorders, Cancer (Malignant Neoplastic
Diseases), and Immune System Disorders. We are making no other
revisions to these body systems in this final rule. This extension
ensures that we will continue to have the criteria we need to evaluate
impairments in the affected body systems at step three of the
sequential evaluation processes for initial claims and continuing
disability reviews.
DATES: This final rule is effective on September 11, 2025.
FOR FURTHER INFORMATION CONTACT: Michael J. Goldstein, Director, Office
of Medical Policy, Social Security Administration, 6401 Security
Boulevard, Baltimore, MD 21235-6401, (410) 965-1020.
For information on eligibility or filing for benefits, call our
national toll-free number, 1-800-772-1213, or TTY 1-800-325-0778, or
visit our internet site, Social Security Online, at <a href="https://www.socialsecurity.gov">https://www.socialsecurity.gov</a>.
SUPPLEMENTARY INFORMATION:
Background
We use the listings in appendix 1 to subpart P of part 404 of 20
CFR at the third step of the sequential evaluation process to evaluate
claims filed by adults and children for benefits based on disability
under the title II and title XVI programs.\1\ 20 CFR 404.1520(d),
416.920(d), 416.924(d). The listings are in two parts: Part A has
listings criteria for adults and Part B has listings criteria for
children. If you are age 18 or over, we apply the listings criteria in
Part A when we assess your impairment or combination of impairments. If
you are under age 18, we first use the criteria in Part B of the
listings when we assess your impairment(s). If the criteria in Part B
do not apply, we may use the criteria in Part A when those criteria
consider the effects of your impairment(s). 20 CFR 404.1525(b),
416.925(b).
---------------------------------------------------------------------------
\1\ We also use the listings in the sequential evaluation
processes we use to determine whether a beneficiary's disability
continues. See 20 CFR 404.1594, 416.994, and 416.994a.
---------------------------------------------------------------------------
Explanation of Changes
In this final rule, we are extending the dates on which the
listings for the following 13 body systems will no longer be effective
as set out in the following chart:
----------------------------------------------------------------------------------------------------------------
Body system listings Current expiration date New expiration date
----------------------------------------------------------------------------------------------------------------
Low Birth Weight and Failure to Thrive August 14, 2026............ August 15, 2031.
100.00.
Musculoskeletal Disorders 1.00 and April 2, 2026.............. April 4, 2031.
101.00.
Special Senses and Speech 2.00 and June 5, 2026............... June 6, 2031.
102.00.
Respiratory Disorders 3.00 and 103.00... December 12, 2025.......... December 13, 2030.
Cardiovascular System 4.00 and 104.00... February 6, 2026........... February 7, 2031.
Genitourinary Disorders 6.00 and 106.00. December 12, 2025.......... December 13, 2030.
Hematological Disorders 7.00 and 107.00. June 5, 2026............... June 6, 2031.
Endocrine Disorders 9.00 and 109.00..... August 14, 2026............ August 15, 2031.
Congenital Disorders That Affect June 5, 2026............... June 6, 2031.
Multiple Body Systems 10.00 and 110.00.
Neurological Disorders 11.00 and 111.00. September 29, 2025......... September 27, 2030.
Mental Disorders 12.00 and 112.00....... December 12, 2025.......... December 13, 2030.
Cancer (Malignant Neoplastic Diseases) August 14, 2026............ August 15, 2031.
13.00 and 113.00.
Immune System Disorders 14.00 and 114.00 February 6, 2026........... February 7, 2031.
----------------------------------------------------------------------------------------------------------------
We continue to revise and update the listings on a regular basis,
including those body systems not affected by this final rule.\2\ We
intend to update the 13 listings affected by this final rule as
necessary based on medical advances as quickly as possible, but may not
be able to publish final rules revising these listings by the current
expiration date. Therefore, we are extending the expiration dates
listed above.
---------------------------------------------------------------------------
\2\ We established the current expiration date of the
Musculoskeletal Disorders body system on Dec. 3, 2020. 85 FR 78164.
We last extended the expiration date of the Neurological Disorders
body system on Aug. 2, 2021. 86 FR 41382. We last extended the
expiration dates of the body systems for Respiratory Disorders,
Genitourinary Disorders, and Mental Disorders on Nov. 17, 2021. 86
FR 64068. We last extended the expiration dates of the body systems
for the Cardiovascular System and Immune System Disorders on Dec.
13, 2021. 86 FR 70728. We last extended the expiration dates of the
body systems for Low Birth Weight and Failure to Thrive, Endocrine
Disorders, and Cancer (Malignant Neoplastic Diseases) on July 18,
2022. 87 FR 42642. We last extended the expiration dates of the body
systems for Special Senses and Speech, Hematological Disorders, and
Congenital Disorders That Affect Multiple Body Systems on May 4,
2022. 87 FR 26268.
---------------------------------------------------------------------------
Regulatory Procedures
Justification for Final Rule
We follow the Administrative Procedure Act (APA) rulemaking
procedures specified in 5 U.S.C. 553 in promulgating regulations.
Section 702(a)(5) of the Social Security Act, 42 U.S.C. 902(a)(5).
Generally, the APA requires that an agency provide prior notice and
opportunity for public comment before issuing a final regulation. The
APA provides exceptions to the notice-and-comment requirements when an
agency finds there is good cause for dispensing with such procedures
because they are impracticable, unnecessary, or contrary to the public
interest.
We determined that good cause exists for dispensing with the notice
and public comment procedures. 5 U.S.C. 553(b)(B). This final rule only
extends the date on which the 13 body system listings will no longer be
effective. It makes no substantive changes to our rules. Our current
regulations \3\ provide that we may extend, revise, or promulgate the
body system listings again. Therefore, we determined that opportunity
for prior comment is
[[Page 43912]]
unnecessary, and we are issuing this regulation as a final rule.
---------------------------------------------------------------------------
\3\ See the first sentence of appendix 1 to subpart P of part
404 of 20 CFR.
---------------------------------------------------------------------------
In addition, for the reasons cited above, we find good cause for
dispensing with the 30-day delay in the effective date of this final
rule. 5 U.S.C. 553(d)(3). We are not making any substantive changes to
the listings in these body systems. Without an extension of the
expiration date for these listings, we will not have the criteria we
need to assess medical impairments in these 13 body systems at step
three of the sequential evaluation processes. We therefore find it is
in the public interest to make this final rule effective on the
publication date.
Executive Order 12866, as Supplemented by Executive Order 13563
We consulted with the Office of Management and Budget (OMB) and
determined that this final rule does not meet the requirements for a
significant regulatory action under Executive Order 12866, as
supplemented by Executive Order 13563. Therefore, OMB did not review
it. We also determined that this final rule meets the plain language
requirement of Executive Order 12866.
Regulatory Flexibility Act
We certify that this final rule does not have a significant
economic impact on a substantial number of small entities because it
affects only individuals. Therefore, a regulatory flexibility analysis
is not required under the Regulatory Flexibility Act, as amended.
Paperwork Reduction Act
This final rule only extends the date for the medical listings
cited above, but does not create any new or affect any existing
collections, or otherwise change any content of the currently published
rules. Accordingly, it does not impose any burdens under the Paperwork
Reduction Act and does not require OMB approval.
(Federal Assistance Listing Nos. 96.001, Social Security--Disability
Insurance; 96.002, Social Security--Retirement Insurance; 96.004,
Social Security--Survivors Insurance; 96.006, Supplemental Security
Income)
List of Subjects in 20 CFR Part 404
Administrative practice and procedure, Blind, Disability benefits,
Old-age, Survivors and disability insurance, Reporting and
recordkeeping requirements, Social Security.
For the reasons set out in the preamble, we are amending appendix 1
to subpart P of part 404 of chapter III of title 20 of the Code of
Federal Regulations as set forth below.
PART 404--FEDERAL OLD-AGE, SURVIVORS AND DISABILITY INSURANCE
(1950-)
Subpart P--Determining Disability and Blindness
0
1. The authority citation for subpart P of part 404 continues to read
as follows:
Authority: 42 U.S.C. 402, 405(a)-(b) and (d)-(h), 416(i),
421(a) and (h)-(j), 422(c), 423, 425, 902(a)(5), and 1320e-3; sec.
211(b), Pub. L. 104-193, 110 Stat. 2105, 2189; sec. 202, Pub. L.
108-203, 118 Stat. 509 (42 U.S.C. 902 note).
0
2. Amend appendix 1 to subpart P of part 404 in the introductory text
by revising items 1 through 5, 7 and 8, and 10 through 15 to read as
follows:
Appendix 1 to Subpart P of Part 404--Listing of Impairments
* * * * *
1. Low Birth Weight and Failure to Thrive (100.00): August 15,
2031.
2. Musculoskeletal Disorders (1.00 and 101.00): April 4, 2031.
3. Special Senses and Speech (2.00 and 102.00): June 6, 2031.
4. Respiratory Disorders (3.00 and 103.00): December 13, 2030.
5. Cardiovascular System (4.00 and 104.00): February 7, 2031.
* * * * *
7. Genitourinary Disorders (6.00 and 106.00): December 13, 2030.
8. Hematological Disorders (7.00 and 107.00): June 6, 2031.
* * * * *
10. Endocrine Disorders (9.00 and 109.00): August 15, 2031.
11. Congenital Disorders That Affect Multiple Body Systems
(10.00 and 110.00): June 6, 2031.
12. Neurological Disorders (11.00 and 111.00): September 27,
2030.
13. Mental Disorders (12.00 and 112.00): December 13, 2030.
14. Cancer (Malignant Neoplastic Diseases) (13.00 and 113.00):
August 15, 2031.
15. Immune System Disorders (14.00 and 114.00): February 7,
2031.
* * * * *
Frank J. Bisignano,
Commissioner, Social Security Administration.
[FR Doc. 2025-17560 Filed 9-10-25; 8:45 am]
BILLING CODE 4191-02-P
</pre></body>
</html>Indexed from Federal Register on September 11, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.